73 related articles for article (PubMed ID: 8893868)
1. A molecular genetic model of human bladder cancer pathogenesis.
Reznikoff CA; Belair CD; Yeager TR; Savelieva E; Blelloch RH; Puthenveettil JA; Cuthill S
Semin Oncol; 1996 Oct; 23(5):571-84. PubMed ID: 8893868
[TBL] [Abstract][Full Text] [Related]
2. Overcoming cellular senescence in human cancer pathogenesis.
Yeager TR; DeVries S; Jarrard DF; Kao C; Nakada SY; Moon TD; Bruskewitz R; Stadler WM; Meisner LF; Gilchrist KW; Newton MA; Waldman FM; Reznikoff CA
Genes Dev; 1998 Jan; 12(2):163-74. PubMed ID: 9436977
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk modeling of tumor stage and survival in bladder cancer.
Nascimben M; Rimondini L; Corà D; Venturin M
BioData Min; 2022 Sep; 15(1):23. PubMed ID: 36175974
[TBL] [Abstract][Full Text] [Related]
4. Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.
Złowocka-Perłowska E; Tołoczko-Grabarek A; Lubiński J
Hered Cancer Clin Pract; 2022 Jan; 20(1):1. PubMed ID: 34983599
[TBL] [Abstract][Full Text] [Related]
5. LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1.
Zhang D; Li S; Yu W; Chen C; Liu T; Sun Y; Zhao Z; Liu L
Cancer Manag Res; 2018; 10():4349-4361. PubMed ID: 30349368
[TBL] [Abstract][Full Text] [Related]
6. In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors.
Brassesco MS; Pezuk JA; Morales AG; de Oliveira JC; Roberto GM; da Silva GN; Francisco de Oliveira H; Scrideli CA; Tone LG
Cancer Biol Ther; 2013 Jul; 14(7):648-57. PubMed ID: 23792639
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Aurora-A oncogenic potential by c-Myc downregulation.
Yang S; He S; Zhou X; Liu M; Zhu H; Wang Y; Zhang W; Yan S; Quan L; Bai J; Xu N
Exp Mol Med; 2010 Nov; 42(11):759-67. PubMed ID: 20890087
[TBL] [Abstract][Full Text] [Related]
8. Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).
Pollard C; Smith SC; Theodorescu D
Expert Rev Mol Med; 2010 Mar; 12():e10. PubMed ID: 20334706
[TBL] [Abstract][Full Text] [Related]
9. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
Wu XR
Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
He F; Mo L; Zheng XY; Hu C; Lepor H; Lee EY; Sun TT; Wu XR
Cancer Res; 2009 Dec; 69(24):9413-21. PubMed ID: 19951992
[TBL] [Abstract][Full Text] [Related]
11. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.
Badawi H; Ahmed H; Ismail A; Diab M; Moubarak M; Badawy A; Saber M
Medscape J Med; 2008; 10(10):232. PubMed ID: 19099026
[TBL] [Abstract][Full Text] [Related]
12. Late effects on the urinary bladder in patients treated for cancer in childhood: a report from the Children's Oncology Group.
Ritchey M; Ferrer F; Shearer P; Spunt SL
Pediatr Blood Cancer; 2009 Apr; 52(4):439-46. PubMed ID: 18985721
[TBL] [Abstract][Full Text] [Related]
13. Immortalization of human urothelial cells by human papillomavirus type 16 E6 and E7 genes in a defined serum-free system.
Carmean N; Kosman JW; Leaf EM; Hudson AE; Opheim KE; Bassuk JA
Cell Prolif; 2007 Apr; 40(2):166-84. PubMed ID: 17472725
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expressions of uPA and its receptor uPAR and their prognostic significant in urinary bladder carcinoma.
El-Kott AF; Khalil AM; El-Kenawy Ael-M
Int Urol Nephrol; 2004; 36(3):417-23. PubMed ID: 15783118
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.
Matsumoto H; Matsuyama H; Fukunaga K; Yoshihiro S; Wada T; Naito K
Br J Cancer; 2004 Sep; 91(6):1025-31. PubMed ID: 15292937
[TBL] [Abstract][Full Text] [Related]
16. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
17. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Seraj MJ; Harding MA; Gildea JJ; Welch DR; Theodorescu D
Clin Exp Metastasis; 2000; 18(6):519-25. PubMed ID: 11592309
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.
Kirimlioglu H; Dvorchick I; Ruppert K; Finkelstein S; Marsh JW; Iwatsuki S; Bonham A; Carr B; Nalesnik M; Michalopoulos G; Starzl T; Fung J; Demetris A
Hepatology; 2001 Sep; 34(3):502-10. PubMed ID: 11526535
[TBL] [Abstract][Full Text] [Related]
19. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.
Billerey C; Chopin D; Aubriot-Lorton MH; Ricol D; Gil Diez de Medina S; Van Rhijn B; Bralet MP; Lefrere-Belda MA; Lahaye JB; Abbou CC; Bonaventure J; Zafrani ES; van der Kwast T; Thiery JP; Radvanyi F
Am J Pathol; 2001 Jun; 158(6):1955-9. PubMed ID: 11395371
[TBL] [Abstract][Full Text] [Related]
20. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
Grippo PJ; Sandgren EP
Am J Pathol; 2000 Sep; 157(3):805-13. PubMed ID: 10980120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
